Please use this identifier to cite or link to this item:
Title: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)
Authors: Thura, Min
Al-Aidaroos, Abdul Qader
Gupta, Abhishek 
Chee, Cheng Ean 
Lee, Soo Chin 
Hui, Kam Man 
Li, Jie
Guan, Yeoh Khay 
Yong, Wei Peng 
So, Jimmy
Chng, Wee Joo 
Ng, Chin Hin 
Zhou, Jianbiao 
Wang, Ling Zhi
Yuen, John Shyi Peng
Ho, Henry Sun Sien 
Yi, Sim Mei
Chiong, Edmund 
Choo, Su Pin 
Ngeow, Joanne
Ng, Matthew Chau Hsien 
Chua, Clarinda
Yeo, Eugene Shen Ann 
Tan, Iain Bee Huat 
Sng, Joel Xuan En
Tan, Nicholas Yan Zhi
Thiery, Jean Paul 
Goh, Boon Cher 
Zeng, Qi 
Keywords: Science & Technology
Multidisciplinary Sciences
Science & Technology - Other Topics
Issue Date: 2-Nov-2021
Citation: Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi (2021-11-02). PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019). NATURE COMMUNICATIONS 12 (1). ScholarBank@NUS Repository.
Abstract: In this article the funding from ‘Open Fund-Individual Research Grant (OF-IRG), National Medical Research Council (NMRC) Singapore with the project ID of NMRC/OFIRG/0053/2017’ was omitted.
ISSN: 20411723
DOI: 10.1038/s41467-021-26548-6
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
PRL3zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.Thura et al.NatComm.2019.pdf4.56 MBAdobe PDF



Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.